Juliet Tammenoms Bakker, Director at RxSight, Inc. (RXST), bought 8,000 shares at $51.29 ($407K) on 2024-02-14, disclosed to the SEC on 2024-02-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.38 | 4,000 | $202K | 49.6% |
| 2 | $51.29 | 4,000 | $205K | 50.4% |
| Total | $50.84 avg | 8,000 | $407K | 100% |
| Filing → |
| RXST | SELL | 2023-11-30 | $29.4M | — | Filing → |
| RXST | SELL | 2023-11-16 | $13.6M | — | Filing → |
| RXST | SELL | 2023-09-11 | $2.0M | — | Filing → |